Disc Medicine, Inc. cash flow to debt ratio of -9.68K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Disc Medicine, Inc.'s free cash flow has decreased 92.02% from $-94.43M last year to $-181.33M, signaling decreasing performance

Disc Medicine, Inc.'s debt to equity ratio is 0.05, which means that the company's assets are healthy financed, signaling financial stability. READ MORE: A ratio under 0.60 means the company finances its assets with own equity, signaling financial stability and good management.

Disc Medicine, Inc.'s debt has decreased relative to shareholder equity from 0.07 last year to 0.05 today, signaling strengthened financials

Disc Medicine, Inc. has negative EBITDA, making leverage ratio unreliable

Disc Medicine, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Disc Medicine, Inc. has insufficient data to evaluate this check.

Disc Medicine, Inc.'s short-term assets of $803.90M exceed its short-term liabilities of $36.64M

Disc Medicine, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Disc Medicine, Inc.'s return on equity of -36.95%, is lower than 15.00%, indicating bad performance

Disc Medicine, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Disc Medicine, Inc. had positive net income in only 0.00 out of 5 years, indicating unstable earnings

Disc Medicine, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Disc Medicine, Inc. has negative free cash flow, indicating cash burn

Disc Medicine, Inc.'s yearly earnings has decreased 94.03% since last year from $-109.36M to $-212.18M, signaling decreasing performance

Disc Medicine, Inc.'s yearly revenue has increased 0.00% since last year from $0.00 to $0.00, signaling increasing performance

ROIC -36.92% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Disc Medicine, Inc. has insufficient revenue history to calculate 3-year revenue CAGR.

Disc Medicine, Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance

Disc Medicine, Inc. had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

Disc Medicine, Inc. has insufficient data to evaluate this check.

Disc Medicine, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Disc Medicine, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Disc Medicine, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Disc Medicine, Inc. has insufficient data to evaluate this check.

Disc Medicine, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Disc Medicine, Inc. has a price-to-book ratio of 4.19x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Disc Medicine, Inc. has a price-to-sales ratio of 999.00x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue